Copyright © 1997 by the European Society of Cardiology.
© 1997 The European Society of Cardiology
How European cardiologists perceive the role of calcium antagonists in the treatment of stable angina


Department of Cardiology, Royal Brompton Hospital London, UK
* KAS Gentoffe, Cardiovascular Laboratory P Hellerup, Denmark
Chair of Cardiology, University of Brescia Brescia, IRCCS Salvatore Maugeri Foundation Gussago, Brescia, Italy
The National Swedish Board of Health and Welfare Stockholm, Sweden
Correspondence: Prof. Roberto Ferrari, Chair of Cardiology, University of Brescia, Spedali Civili, P.le Spedali Civili, 1, 25123 Brescia, Italy
Some 100 European cardiologists discussed calcium antagonists' role in the management of stable angina. Sixty-two percent of those involved used calcium antagonists rather than beta-blockers as first line therapy; 46% were prepared to use calcium antagonists in patients who had had a myocardial infarction more than 6 months previously. Only one tenth would use calcium antagonists in angina patients with left ventricular dysfunction. There was a broad preference for the use of heart rate-moderating calcium antagonists in most forms of stable angina. The discussions also underlined the diagnostic importance of angiography, exercise testing and lipid profile analysis.
Key Words: Calcium antagonists β-blockers myocardial infarction prognosis diagnosis